CHRISTUS Shreveport-Bossier Health System Expands Cardiovascular Services With New Electrophysiology Lab
First in the Region to Install Next Generation technology tailored treatment for patients with cardiac arrhythmias
June 23, 2017
CHRISTUS Shreveport-Bossier Health System is the first facility in the region to install the EnSite Precision™ cardiac mapping system and was among the first sites in the United States to utilize this technology. CHRISTUS opened a new Electrophysiology Lab (EP Lab) as a part of the growing cardiovascular services on the Highland campus and invested in this new EnSite Precision technology as a part of that expansion. The EP lab focuses on the electrical function on the heart and offers patients the opportunity to have their irregular heartbeat tested, diagnosed and treated.
“We are proud to offer EnSite Precision for cardiac patients suffering with heart arrhythmias and other electrical-related cardiac conditions,” Isaac Palmer, CEO CHRISTUS Shreveport-Bossier Health System, said. “This new technology is like having a GPS system inside your heart. In the expert hands of our cardiovascular physicians, this exciting new technology allows the physicians to locate a wide range of arrhythmias and helps to tailor treatment more quickly and accurately.”
Ensite Precision is a next-generation platform designed to provide cardiologists automation, flexibility and accuracy for diagnostic mapping used in ablation procedures to treat patients with abnormal heart rhythms (cardiac arrhythmias).
“I am excited that my patients will get to use this technology at CHRISTUS Highland Medical Center,” Dr. Scott Wiggins, cardiologist at the CHRISTUS Cath Lab, said. “One of the distinctive features of the EnSite Precision cardiac mapping system is that it uses intelligent automation tools, which are designed to enable faster and more accurate high density maps allowing tailored treatment for a variety of cardiac arrhythmias, including complex cases. The ability to create rapid high-resolution models, speeds up mapping time and minimizes fluoroscopic radiation exposure for both the patient and the clinicians.”
In addition to the Ensite Precision technology, the EP lab allows physicians the ability to treat and diagnose patients with electrical function issues of the heart in more invasive and advanced ways. The most common arrhythmia is atrial fibrillation, affecting more than 3 million Americans and millions more worldwide. Atrial fibrillation, also called AF or Afib, is a very fast, irregular heartbeat that occurs when the upper chambers of the heart beat so fast that they only can quiver. Atrial fibrillation can be dangerous, as over time it can cause more serious conditions such as stroke.
“We have three of the best cardiologist, Dr. Trey Baucum, Dr. Scott Wiggins, and Dr. Srikar Veerareddy, using our EP Lab to help those patients with irregular heartbeats get faster diagnosis and treatments,” Palmer said. “As our cardiology services expand on our Highland campus, we are dedicated to meeting the needs of our patients and physicians and still providing the faith-based, personalized care our community has come to know and expect.”
Dr. Srikar Veerareddy started treating and diagnosing patients in the new EP lab earlier this year with the latest technology the EP lab offers as well as the experience and knowledge of the specially trained staff at the CHRISTUS Cath Lab.
“Since CHRISTUS opened the new EP lab, I am able to perform a full range of invasive procedures for cardiac arrhythmias including pacemakers, defibrillators and ablations for supraventricular tachycardia (SVT). I am also able to utilize the latest technology to treat arrhythmias including ventricular tachycardia (VT), premature ventricular contractions (PVC), atrial fibrillation and other complex left atrial arrhythmias. I even implanted the world’s smallest leadless pacemaker into a patient because of the capabilities this new EP lab and the skilled staff.”